CD4 and neoplasm: Since in the context of autoimmune diseases, a large percentage of CD4+ T cells may be killed via TNF-related apoptosis-inducing ligand (TRAIL) or perforin and granzyme B, leading to CD4+ T-cell exhaustion [83,84], it is tempting to hypothesize that these mechanisms operate to promote tumor development.